• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身性皮质类固醇使用的风险。

The risks of systemic corticosteroid use.

作者信息

Lester R S, Knowles S R, Shear N H

机构信息

Division of Dermatology, Sunnybrook Health Science Centre, University of Toronto, Ontario, Canada.

出版信息

Dermatol Clin. 1998 Apr;16(2):277-88. doi: 10.1016/s0733-8635(05)70010-3.

DOI:10.1016/s0733-8635(05)70010-3
PMID:9589201
Abstract

Because of their potent antiinflammatory and immunosuppressive properties, systemic corticosteroids are used to modify a vast array of diseases. This class of drugs, however, has the potential to produce multiple adverse effects presenting the dermatologist with difficult decisions in the management of patients with potentially steroid responsive disorders. This article reviews the side effects of systemic corticosteroids, comments on strategies to minimize these side effects, as well as, outlining suggested mechanisms by which physicians may minimize the risks of medical legal consequences owing to adverse reactions to these drugs.

摘要

由于其强大的抗炎和免疫抑制特性,全身性皮质类固醇被用于治疗多种疾病。然而,这类药物有可能产生多种不良反应,这给皮肤科医生在管理可能对类固醇有反应的疾病患者时带来了艰难的决策。本文回顾了全身性皮质类固醇的副作用,评论了将这些副作用降至最低的策略,并概述了医生可通过哪些建议机制将因这些药物不良反应导致的医疗法律后果风险降至最低。

相似文献

1
The risks of systemic corticosteroid use.全身性皮质类固醇使用的风险。
Dermatol Clin. 1998 Apr;16(2):277-88. doi: 10.1016/s0733-8635(05)70010-3.
2
Oral Corticosteroids for Skin Disease in the Older Population: Minimizing Potential Adverse Effects.老年人皮肤疾病的口服皮质类固醇治疗:尽量减少潜在的不良反应。
Drugs Aging. 2024 Oct;41(10):795-808. doi: 10.1007/s40266-024-01143-8. Epub 2024 Sep 16.
3
Psychiatric adverse effects of pediatric corticosteroid use.儿童皮质类固醇使用的精神不良反应。
Mayo Clin Proc. 2014 Jun;89(6):817-34. doi: 10.1016/j.mayocp.2014.01.010.
4
Systemic steroid therapy with intramuscularly injected triamcinolone.采用肌肉注射曲安奈德进行全身类固醇治疗。
South Med J. 1978 Feb;71(2):102-7. doi: 10.1097/00007611-197802000-00004.
5
[Internal and external therapy with corticoids].[皮质类固醇的内外治疗]
Z Hautkr. 1990 Jun;65(6):527-30, 533.
6
Reducing the problems of corticosteroid therapy.减少皮质类固醇疗法的问题。
Br J Hosp Med. 1977 Oct;18(4):360-3, 365.
7
[Experimental and clinical appraisal of corticosteroids applied topically. II. Clinical studies].[局部应用皮质类固醇的实验与临床评估。II. 临床研究]
Przegl Dermatol. 1974 Sep-Oct;61(5):709-13.
8
Ocular side-effects of topical corticosteroids: what a dermatologist needs to know.局部用皮质类固醇的眼部副作用:皮肤科医生需要了解的内容。
Australas J Dermatol. 2015 Aug;56(3):164-9. doi: 10.1111/ajd.12292. Epub 2015 Mar 5.
9
Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy.全身性皮质类固醇治疗季节性变应性鼻炎:一种常见但记录不足的疗法。
Allergy. 2000 Jan;55(1):11-5. doi: 10.1034/j.1398-9995.2000.00108.x.
10
Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases.皮损内注射皮质类固醇治疗皮肤病的益处与风险。
Clin Exp Dermatol. 1995 Sep;20(5):363-70. doi: 10.1111/j.1365-2230.1995.tb01351.x.

引用本文的文献

1
CAR T-cell therapy in autoimmune diseases: a promising frontier on the horizon.自身免疫性疾病中的嵌合抗原受体T细胞疗法:一个充满前景的前沿领域。
Front Immunol. 2025 Aug 12;16:1613878. doi: 10.3389/fimmu.2025.1613878. eCollection 2025.
2
Machine learning for refining interpretation of magnetic resonance imaging scans in the management of multiple sclerosis: a narrative review.机器学习在多发性硬化症管理中优化磁共振成像扫描解读的应用:一项叙述性综述
R Soc Open Sci. 2025 Jan 22;12(1):241052. doi: 10.1098/rsos.241052. eCollection 2025 Jan.
3
TMX1, a disulfide oxidoreductase, is necessary for T cell function through regulation of CD3ζ.
TMX1是一种二硫键氧化还原酶,通过调节CD3ζ对T细胞功能至关重要。
bioRxiv. 2024 Sep 24:2024.09.22.614388. doi: 10.1101/2024.09.22.614388.
4
Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing.严重 COVID-19 患者的免疫相关蛋白互作网络研究,以鉴定关键蛋白和药物再利用。
Biomolecules. 2022 May 11;12(5):690. doi: 10.3390/biom12050690.
5
A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms.关于用于重症新型冠状病毒肺炎以预防细胞因子风暴的全身性皮质类固醇激素的作用及副作用的综述
EXCLI J. 2021 Feb 15;20:339-365. doi: 10.17179/excli2020-3196. eCollection 2021.
6
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.利妥昔单抗对寻常型天疱疮患者是一种有效的治疗方法,并具有激素节省作用。
Br J Dermatol. 2020 May;182(5):1111-1119. doi: 10.1111/bjd.18482. Epub 2019 Nov 28.
7
A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata.口服环孢素与倍他米松小剂量冲击疗法治疗斑秃的对比研究
Ann Dermatol. 2016 Oct;28(5):569-574. doi: 10.5021/ad.2016.28.5.569. Epub 2016 Sep 30.
8
N-(2-hydroxy phenyl) acetamide: a novel suppressor of Toll-like receptors (TLR-2 and TLR-4) in adjuvant-induced arthritic rats.N-(2-羟基苯基)乙酰胺:佐剂诱导性关节炎大鼠中Toll样受体(TLR-2和TLR-4)的新型抑制剂
Mol Cell Biochem. 2014 Sep;394(1-2):67-75. doi: 10.1007/s11010-014-2082-7. Epub 2014 May 21.
9
Synergistic anti-inflammatory effects of Laminaria japonica fucoidan and Cistanche tubulosa extract.海带岩藻聚糖与管花肉苁蓉提取物的协同抗炎作用。
Lab Anim Res. 2012 Jun;28(2):91-7. doi: 10.5625/lar.2012.28.2.91. Epub 2012 Jun 26.
10
The anti-arthritic and anti-oxidative effect of NBD (6-nitro-1,3-benzodioxane) in adjuvant-induced arthritis (AIA) in rats.NBD(6-硝基-1,3-苯并二氧杂环戊烷)在大鼠佐剂性关节炎(AIA)中的抗关节炎和抗氧化作用。
Inflamm Res. 2012 Aug;61(8):875-87. doi: 10.1007/s00011-012-0480-4. Epub 2012 Apr 27.